Educating Hispanics About Clinical Trials and Biobanking
- 143 Downloads
Hispanics are under-represented in clinical research. To ensure that the Hispanic population benefits from advances in public health and medicine, including personalized medicine, there is a need to increase their participation in clinical trials and biobanking. There is a great need for improving awareness and addressing concerns individuals may have about participation. The purpose of this study was to adapt, implement, and evaluate educational materials about clinical trials and biobanking for Hispanic individuals. We adapted existing materials based on focus group data. We then trained four promotoras de salud to deliver education to Hispanic adults in community settings in Houston, TX. The promotoras educated 101 Hispanic adults, 51 on biobanking and 50 on clinical trials. Study staff administered brief pre- and post-test questionnaires that measured benefits, barriers, norms, self-efficacy, and intention to participate in either clinical trials or biobanking. Our sample was predominately female (83%) and Spanish-speaking (69%) and made less than $25,000 a year (87%). This intervention increased perceived benefits of participating in biobanking and clinical trials, self-efficacy for donating biospecimens, and intention to participate in biobanking if invited. Perceived barriers to participating declined. This study demonstrated that brief education can result in improved perceptions and attitudes related to participation in biobanking and clinical trials, and could increase participation. Researchers and practitioners could use these educational materials to educate Hispanic community members on clinical research potentially increasing participation rates in the future.
KeywordsBiobanking Clinical trials Cancer education Hispanics
The authors thank the promotoras from Prosalud for their valuable assistance in recruiting participants and delivering the intervention. The authors also acknowledge using materials on biobanking and clinical trials, specifically for Hispanics, from the University of Texas Health Science Center at San Antonio and Moffitt Cancer Center.
The project received funding from the Center of Clinical and Translational Sciences, which is funded mainly by the National Center for Advancing Translational Sciences, Centers for Translational Science Award (UL1 TR000371), the UTHealth School of Public Health Cancer Education, Career Development Program through a National Cancer Institute/NIH grant (R25CA57712), and partial funding from the Center for Health Promotion and Prevention Research. This work was also supported by the Duncan Family Institute for Cancer Prevention and Risk Assessment.
Compliance with Ethical Standards
The University of Texas Health Science Center’s Institutional Review Board approved the study.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.
- 1.Gehlert SJ (2016) Abstract IA40: maximizing the benefits of precision medicine for cancer disparities. AACRGoogle Scholar
- 7.Scott EA, Schlumpf KS, Mathew SM, Mast AE, Busch MP, Gottschall JL, for the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II) (2010) Biospecimen repositories: are blood donors willing to participate? Transfusion 50(9):1943–1950PubMedPubMedCentralCrossRefGoogle Scholar
- 15.Calderón JL, Baker RS, Fabrega H, Conde JG, Hays RD, Fleming E, Norris K (2006) An ethno-medical perspective on research participation: a qualitative pilot study. Medscape Gen Med 8(2):23Google Scholar
- 18.Jacobsen PB, Wells KJ, Meade CD, Quinn GP, Lee JH, Fulp WJ, Gray JE, Baz RC, Springett GM, Levine RM, Markham MJ, Schreiber FJ, Cartwright TH, Burke JM, Siegel RD, Malafa MP, Sullivan D (2012) Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. J Clin Oncol 30(20):2516–2521PubMedPubMedCentralCrossRefGoogle Scholar
- 19.Manne S, Kashy D, Albrecht T, Wong YN, Flamm AL, Benson AB III, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ (2014) Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model. Med Decis Mak 34(4):454–463CrossRefGoogle Scholar
- 22.Ma GX et al (2013) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Prev Biomarkers p. cebp. 0773.2013Google Scholar
- 27.McIntyre J et al (2017) Comparison of health communication channels for reaching Hispanics about biobanking: a pilot trial. J Cancer Educ:1–9Google Scholar
- 34.Trevino-Whitaker R et al (2013) Clinical trials outreach for Latinos: program replication manual. Institute for Health Promotion Research. University of Texas Health Science Center at San AntonioGoogle Scholar
- 35.Treviño-Whitaker RA et al (2015) Abstract A39: GMaP Region 4 clinical trials outreach for Latinos. AACRGoogle Scholar
- 37.Bartholomew-Eldredge LK et al (2016) Planning health promotion programs: an intervention mapping approach. Jossey-Bass, San FranciscoGoogle Scholar
- 38.Durant RW, Wenzel JA, Scarinci IC, Paterniti DA, Fouad MN, Hurd TC, Martin MY (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(S7):1097–1105PubMedPubMedCentralCrossRefGoogle Scholar
- 40.Young J (2009) Clinical pediatrics in the Mexican immigrant community. Contemp Pediatr 26(4):58–64Google Scholar